de Parades Vincent, Bauer Pierre, Marteau Philippe, Chauveinc Laurent, Bouillet Thierry, Atienza Patrick
Service de proctologie médico-interventionnelle, Groupe hospitalier Diaconesses - Croix Saint-Simon, F-75012 Paris, France.
Presse Med. 2008 Jul-Aug;37(7-8):1113-20. doi: 10.1016/j.lpm.2007.07.020. Epub 2008 Feb 20.
The incidence of radiation-induced chronic hemorrhagic proctitis is less than 10 to 20%. The onset of this proctitis is delayed relative to the radiation therapy and generally develops from 6 to 24 months later. There are numerous predisposing factors, the most important of which is the radiation therapy dose: risk increases exponentially above 40-45 Gy. Its pathophysiology involves progressive obliterating endarteritis and transmural interstitial fibrosis, which induce chronic ischemia that is irreversible and progressive during the years after radiation therapy. Its diagnosis depends most often on the combination of clinical history and typical endoscopic appearance (congestive mucosa and/or telangiectases). Topical administrative of sucralfate or corticosteroids as well as argon plasma coagulation, with formalin treatment if necessary, provides relief for most patients.
放射性慢性出血性直肠炎的发病率低于10%至20%。这种直肠炎的发病相对于放射治疗有所延迟,通常在放疗后6至24个月出现。有许多诱发因素,其中最重要的是放射治疗剂量:剂量超过40 - 45 Gy时风险呈指数级增加。其病理生理学涉及进行性闭塞性动脉内膜炎和透壁性间质纤维化,这会导致慢性缺血,在放疗后的数年中这种缺血是不可逆且逐渐加重的。其诊断通常取决于临床病史和典型的内镜表现(充血黏膜和/或毛细血管扩张)。大多数患者使用硫糖铝或皮质类固醇局部给药以及氩等离子体凝固治疗,必要时结合福尔马林治疗可缓解症状。